Postmortem studies of patients dying from severe asthma show epithelial damage, with oedema and detachment of cells into the bronchial lumen.' 2 Clusters of epithelial cells in the sputum are more common in asthmatic patients than in non-asthmatic control subjects, and more epithelial cells are present in the sputum of patients with more severe asthma.3 These findings suggest a link between asthma and damage to the bronchial epithelium, and several mechanisms have been proposed"7 by which such damage might lead to the increased bronchial responsiveness characteristic of asthma.8 It has been suggested that stimulation of exposed sensory nerve endings in the airway wall by inflammatory mediators might activate an axon reflex with the subsequent release of sensory neuropeptides that produce or contribute to the pathological changes in asthma. 4 Alternatively, epithelial damage may cause bronchial hyperresponsiveness through the Thorax 1990;45:12-15 production of inflammatory mediators by epithelial cells6 or by a reduction in epithelium derived smooth muscle relaxant factor.7
To investigate the relation between airway hyperresponsiveness and epithelial damage further we have used light and electron microscopy to examine the epithelium in bronchial biopsy specimens taken from patients with mild asthma and airway hyperresponsiveness, and from healthy non-asthmatic subjects who did not show airway hyperresponsiveness.
Methods

PATIENTS
We studied 11 asthmatic patients (mean age 24 years; three male) and 17 healthy nonasthmatic volunteers (mean age 26 years; seven male). All the asthmatic patients showed airway hyperresponsiveness to inhaled methacholine-that is, a 200o fall in FEV, after inhalation of a concentration (PC20FEV,) of methacholine of 4 0 mg/ml or less. All the asthmatic patients had a PC20 FEV, less than 1 mg/ml and all the non-asthmatic subjects had a value greater than 8 mg/ml. All Biopsy specimens from 10 of the asthmatic patients and nine of the healthy subjects (identified in table 1) were examined by light microscopy. The mean maximum FEV, was 9699% predicted in the asthmatic patients and 96-10/0 in the non-asthmatic subjects.
Biopsy specimens from eight of the asthmatic patients and 10 of the healthy subjects (identified in table 1) were studied by electron microscopy. The mean FEV, was 91 10O predicted in the asthmatic patients and 100 4" , in the non-asthmatic subjects. The sections prepared for light microscopy were all examined by the same observer (PR), Sections prepared for electron microscopy were examined independently by a separate observer (CW). Both observers were blind to the presence or absence of asthma. Light microscopy was used to assess goblet cell hyperplasia, epithelial cell loss, squamous metaplasia, and epithelial cell swelling, all of which have previously been described in biopsy specimens taken at bronchoscopy from patients with asthma." 12 *See under "Methods" (below) for the grading of electron microscopy features. tThe differences between the asthmatic and non-asthmatic subjects are not significant (MannWhitney U test). (table 2) . Deviation from parallel of the satellites of basal bodies of ciliary cells, as described in asthma,11 was seen in only one subject, who was not asthmatic. The presence of epithelial nerves close to the bronchial lumen, also described in asthma,"
was seen in one asthmatic and in one nonasthmatic subject. No changes were seen in the cellular junctional complexes in any of the subjects. Biopsy specimens from 18 subjects were processed for electron microscopy, of whom 11 (six asthmatic and five healthy subjects) underwent bronchial biopsy after methacholine provocation and seven (two asthmatic and five healthy subjects) before provocation. There was no difference between these two groups in any of the epithelial changes assessed by electron,microscopy (table 3).
Discussion
It is well recognised from postmortem studies that damage to the bronchial epithelium and detachment of epithelial cells occur in severe asthma,1 2 and several mechanisms"7 have been proposed by which epithelial damage could lead to the increased bronchial responsiveness characteristic of asthma.8 Little information, however, is available on the histology of the bronchial epithelium in patients with mild asthma. In the present study all the asthmatic patients had mild disease not requiring treatment with inhaled or oral corticosteroids, though all required inhaled salbutamol and all showed airway hyperresponsiveness to methacholine.
Shedding of bronchial mucosal cells in severe asthma1 has been attributed to transudation of oedema fluid from the submucosa, observed histologically as separation of epithelial cells.2 In the present study quantitative assessment was made of mean epithelial height, which is diminished by loss of epithelial cells, and intercellular area, which is increased by separation of epithelial cells. These measurements were similar in patients and controls, indicating that neither epithelial oedema nor loss of epithelial cells is a characteristic feature of mild asthma. Jeffrey et al '3 studied biopsy specimens of the bronchial mucus membrane from patients with asthma and also found no increase in epithelial oedema, though there was increased loss of epithelial cells in a small subgroup of four symptomatic patients, whose lung function was not described and who may have had relatively severe disease. In patients with stable asthma and airway hyperresponsiveness to histamine, however, lung epithelial permeability is no greater than in healthy subjects.'8 " These findings are in keeping with our observation that changes in intercellular junctions were not present in patients with mild asthma, and support our conclusion that airway hyperresponsiveness may be present in patients with mild asthma in the absence of apparent morphological change in the bronchial epithelium. Our findings also suggest that damage to the bronchial epithelium with consequent exposure of sensory nerve endings is not a determinant of bronchial hyperresponsiveness in patients with mild asthma. Possibly bronchial hyperresponsiveness in patients with mild asthma results from epithelial damage that causes no morphological change, but leads to production of inflammatory mediators by epithelial cells6 and a reduction in epithelium derived smooth muscle relaxant factor.7
In conclusion, assessment of the degree of bronchial epithelial damage with both electron and light microscopy by observers who were blind to the presence or absence of asthma showed no differences between healthy subjects with normal airway responsiveness and asthmatic patients with airway hyperresponsiveness. These findings indicate that airway hyperresponsiveness may be present when there is no apparent morphological change in the structure of the bronchial epithelium.
